Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
stem cell
Biotech
Preclinical stem cell biotech takes SPAC route to Nasdaq
Stem cell therapy biotech PrimeGen US is taking the less-traveled SPAC route to the public markets.
James Waldron
Feb 4, 2026 10:15am
ReNeuron leaving AIM exchange after missing fundraising goal
Aug 30, 2024 10:30am
Sickle cell gene therapy process may cause cancerous mutations
Nov 20, 2023 9:10am
Omeros saddles up for 2nd charge at transplant drug approval
Mar 14, 2023 9:30am
MaaT wraps up microbiome trial early to power into phase 2/3
Jan 24, 2022 7:20am
Magenta Therapeutics' research lead Davis hits the exit
May 27, 2021 10:40am
